Cormorant Asset Management, LP
EYPTCormorant Asset Management, LP serves as other: Former 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Cormorant Asset Management, LP's Insider Trading at EyePoint Pharmaceuticals, Inc. (EYPT)
Buys
5 · $89.50M
Sells
1 · $942.2K
Total Shares Bought
4,794,057
Total Shares Sold
60,000
Cormorant Asset Management, LP's Insider Trading at Design Therapeutics, Inc. (DSGN)
Buys
1 · $15.00M
Sells
0 · $0.00
Total Shares Bought
750,000
Total Shares Sold
0
Cormorant Asset Management, LP's Insider Trading at Immuneering Corporation (IMRX)
Buys
1 · $8.25M
Sells
2 · $3.91M
Total Shares Bought
550,000
Total Shares Sold
1,309,091
Cormorant Asset Management, LP's Insider Trading at Monte Rosa Therapeutics, Inc. (GLUE)
Buys
1 · $11.40M
Sells
0 · $0.00
Total Shares Bought
600,000
Total Shares Sold
0
Cormorant Asset Management, LP's Insider Trading at Ventyx Biosciences, Inc. (VTYX)
Buys
1 · $10.00M
Sells
0 · $0.00
Total Shares Bought
625,000
Total Shares Sold
0
Cormorant Asset Management, LP's Insider Trading at Pyxis Oncology, Inc. (PYXS)
Buys
1 · $7.20M
Sells
0 · $0.00
Total Shares Bought
450,000
Total Shares Sold
0
Cormorant Asset Management, LP's Insider Trading at Jade Biosciences, Inc. (JBIO)
Buys
1 · $7.00M
Sells
0 · $0.00
Total Shares Bought
500,000
Total Shares Sold
0
Cormorant Asset Management, LP's Insider Trading at Tyra Biosciences, Inc. (TYRA)
Buys
1 · $5.00M
Sells
0 · $0.00
Total Shares Bought
312,500
Total Shares Sold
0
Cormorant Asset Management, LP's Insider Trading at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Buys
0 · $0.00
Sells
1 · $1.74M
Total Shares Bought
0
Total Shares Sold
425,000
Related Insiders
Yong Ben
director
Karen L. Zaderej
director
Nishant C Saxena
officer: Chief Business Officer
Yuval Cohen
director, officer: Chief Executive Officer
Sean F. Moran
officer: Chief Financial Officer
Ramiro Ribeiro
officer: Chief Medical Officer
Benjamin J. Zeskind
director, officer: PRESIDENT AND CEO
Brett Matthew Hall
officer: CHIEF SCIENTIFIC OFFICER